New Injection Technology Sets the Standard for Icon BioSciences

William S. (Sandy) White, President & CEO for Icon BioSciences, discusses the company’s increasing portfolio of products that target most major therapeutic areas of ophthalmology. Stressing the importance of getting the correct drug, in the correct place, with the best clinical approach, Sandy details the progress of their latest products and briefly highlights their newest injection technology.


William S. (Sandy) White

William S. (Sandy) White

William S. (Sandy) White is the CEO and President of Icon Bioscience, Inc. He has over 25 years of broad pharmaceutical industry experience including general management, corporate development/licensing, R&D and sales & marketing.

View Full Profile